Zhejiang Anglikang Pharmaceutical Co Ltd Class A002940
▲ ポジティブ資本関連度
Anglikang invests 50 million yuan to acquire 36.47% stake in Shengruikang, gaining priority cooperation rights for its R&D products.
昂利康は公告で、自己資金5000万元を3期に分けて晟睿康生物医薬(杭州)有限責任公司に増資し、合計で晟睿康の株式36.4706%を取得すると発表した。増資完了後、昂利康はさらに晟睿康の研究開発製品について中華圏での優先的提携権を獲得する。
Zhejiang Anglikang Pharmaceutical Co Ltd Class AAnglikang invests 50 million yuan to acquire 36.47% stake in Shengruikang, gaining priority cooperation rights for its R&D products.
Shengruikang receives 50 million yuan capital injection from Anglikang, valuing the company and providing funds.